Therefore, the present study focused on disrupting the IL-6/STAT-3 pathway in human androgen-independent/highly metastatic PCa DU-145 cells using Stt, an inhibitor of STAT-3, and Tcz, an anti-IL-6R antibody. This evidence concerns the gene IL6R and posterior cortical atrophy.